1. Home
  2. MTEX vs FEMY Comparison

MTEX vs FEMY Comparison

Compare MTEX & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mannatech Incorporated

MTEX

Mannatech Incorporated

N/A

Current Price

$9.02

Market Cap

10.0M

Sector

Health Care

ML Signal

N/A

Logo Femasys Inc.

FEMY

Femasys Inc.

N/A

Current Price

$1.42

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTEX
FEMY
Founded
1993
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.5M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
MTEX
FEMY
Price
$9.02
$1.42
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $16.50
AVG Volume (30 Days)
30.7K
★ 103.5K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.71
EPS
★ 1.02
N/A
Revenue
★ $108,038,000.00
$2,293,313.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$328.45
P/E Ratio
$8.31
★ N/A
Revenue Growth
N/A
★ 40.77
52 Week Low
$3.80
$0.29
52 Week High
$9.97
$6.29

Technical Indicators

Market Signals
Indicator
MTEX
FEMY
Relative Strength Index (RSI) 59.72 40.27
Support Level $6.26 $1.26
Resistance Level $9.65 $3.21
Average True Range (ATR) 0.58 0.13
MACD 0.01 0.04
Stochastic Oscillator 86.21 62.71

Price Performance

Historical Comparison
MTEX
FEMY

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: